Clinical Trials Browser

OTHER × Carcinoma, Transitional Cell × nintedanib × Clear all

NCT02278978 2015-05-12

BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell